Fig. 2
From: UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients
Kaplan-Meier survival curves for ovarian cancer patients according to UCP1 expression levels. A and B High expression of UCP1 is associated with better survival of patients with stage 3 and grade 2 OV. C and D High expression of UCP1 is associated with better survival of OV patients with optimal and suboptimal debulk treatment. E and F High expression of UCP1 is associated with better survival of OV patients with docetaxel and platin chemotherapy